SurpassMD vs Henry Meds: GLP-1 Pricing & Programs Compared
Advertising disclosure: SurpassMD is an advertising partner of Peptide Dossier. Pricing and program facts below were verified in July 2026 and apply to both platforms equally.
SurpassMD and Henry Meds both sell compounded GLP-1 weight loss programs online, but they compete on different axes: SurpassMD on entry price ($134/month semaglutide vs $297) and 48-hour shipping, Henry Meds on oral tirzepatide tablets and consultation depth. Here is the full comparison.
Side-by-Side Comparison (July 2026)
| Feature | SurpassMD | Henry Meds |
|---|---|---|
| Semaglutide (injectable) | From $134/mo | $297/mo (low dose), $397 (high) |
| Semaglutide (oral) | Available | $249-349/mo (tablets/drops) |
| Tirzepatide | From $199/mo (injectable) | $349-449/mo (oral tablets) |
| Oral tirzepatide | Not offered | Yes — key differentiator |
| Dose escalation | Price varies by dose | +$100/mo per tier above 1mg |
| Prepay discounts | Not required for entry price | 6-mo ~$247/mo, 12-mo ~$197/mo |
| Shipping | Cold, within 48 hours | 3-5 business days |
| Consultation style | Async provider review | 30-45 min consult |
| Coaching | Support included | Premium coaching $50-100/mo extra |
| Insurance | Cash-pay only | Cash-pay focus; brand-name possible at much higher cost |
| Coverage | 50 states + DC | Most states |
| Track record | New brand (2026) | Established, multi-year track record |
Where the Price Gap Comes From
The $163/month entry gap on semaglutide is the headline, but the structural difference is dose-tier pricing. Henry Meds adds roughly $100/month per tier above 1mg, so a patient reaching a common maintenance dose can pay $397/month by month six — nearly triple SurpassMD's advertised floor. Henry's prepay plans close some of the gap but require committing $1,482-2,364 upfront.
Henry Meds' genuine edge is form factor: it is one of the only major platforms with oral tirzepatide tablets, which matters for needle-averse patients who want the stronger dual-agonist molecule. See our oral tirzepatide guide for the bioavailability trade-offs.
Verdict: Which Should You Choose?
On price, shipping, and injectable options, SurpassMD leads this matchup. On oral tirzepatide, consultation length, and brand maturity, Henry Meds does. Price-sensitive patients starting injectable semaglutide or tirzepatide have little reason to pay Henry's premium; needle-averse patients set on tirzepatide have little alternative to it.
Full reviews: SurpassMD review and Henry Meds review. Compare the whole field in best GLP-1 telehealth providers and the full price comparison.
Frequently Asked Questions
SurpassMD, by a wide margin at entry: $134/month advertised versus $297/month for injectable compounded semaglutide at Henry Meds as of July 2026. Henry Meds narrows the gap with prepay plans (roughly $197-247/month effective on 12- and 6-month commitments) and its advertised $179 rate applies to liraglutide, not semaglutide. Both platforms may charge more at higher doses.
Yes: oral tirzepatide tablets ($349-449/month), which SurpassMD does not carry — SurpassMD's oral option is semaglutide only. Henry Meds also offers longer 30-45 minute consultations and optional premium nutrition coaching ($50-100/month). Patients who specifically want tirzepatide without injections have few alternatives to Henry Meds among major platforms.
SurpassMD advertises cold-chain shipping within 48 hours of provider approval. Henry Meds typically quotes 3-5 business days from prescription to delivery. Both ship compounded injectables cold-packed with tracking.
At Henry Meds, doses above 1mg semaglutide add roughly $100 per month per tier, so a patient titrating to a typical maintenance dose can pay substantially more than the entry rate by month six. SurpassMD prices are advertised as starting prices that vary by dose and medication, so confirm your expected maintenance-dose cost at checkout. Neither platform offers flat all-dose pricing the way TrimRx does.
Both are digital health platforms that route intakes to independent licensed providers and fill prescriptions through licensed compounding pharmacies, and both are cash-pay models. Henry Meds is the more established brand with a multi-year public track record; SurpassMD is newer (2026) with a shorter one. At both, prescriptions are never guaranteed and compounded medications are not FDA-approved.
Choose SurpassMD if entry price and shipping speed drive the decision: $134/month semaglutide and 48-hour fulfillment lead this matchup. Choose Henry Meds if you want oral tirzepatide tablets, longer consultations, or structured coaching add-ons and will pay the premium. Model your cost at your expected maintenance dose, not the advertised floor, before committing to either.
This page is informational and is not medical advice. SurpassMD is an advertising partner of Peptide Dossier. Compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. Prescriptions are never guaranteed. Pricing verified July 2026 and subject to change.